Improving Tailored Treatment Plans in HR+, HER2- Early Breast Cancer
Genomic profiling in the FLEX trial predicted chemotherapy response in HR+, HER2- breast cancer, which could enable tailored treatment plans.
Read More
Author: Rebecca Shover
Dr. Luis Sumoza on Guiding Patients & Care Teams in CLL
Luis Sumoza, MD, highlights the need to explain the disease, its consequences, and treatment side effects to patients, highlighting effective communication with primary care providers is crucial to ensure coordinated care.
Read More
Dr. Justin Balko on Challenges & Emerging Biomarkers in Breast Cancer
Justin Balko, PharmD, PhD, reviews his session from SABCS 2024 where he discussed the challenges and advancements in immunotherapy for early-stage triple-negative breast cancer (TNBC). Additionally, he discusses the importance of identifying predictive biomarkers to optimize treatment and improve patient quality of life.
Read More
Year in Review – Alzheimer’s Disease
A curated review of what has happened in Alzheimer’s disease research in 2024, including FDA approvals, updated guidelines, and more…
Read More
Semi-Dry Dot-Blot Kit Detects Macrometastases in Patients With Breast Cancer
Physician’s Weekly spoke with Dr. Otsubo and Dr. Hara about their research and how they anticipate the SDB kit will be applied in clinical settings.
Read More
Dual IO in Melanoma with BRAF Gene Mutations
Immunotherapy (IO) has transformed the way certain cancers can be treated over the past decade—positioning it as a critical pillar in cancer therapy.
Read More
Q&A: The Vital Role of Nurses & APs in Enhancing Palliative Care for Patients With Blood Cancer Undergoing Transplant
Physician’s Weekly spoke with Richard Newcomb, MD, on the role of nurses and APs in enhancing palliative care.
Read More
Optimizing Palliative Care Integration in Transplant Among Patients With Blood Cancer
Early palliative care improves transplant patients’ quality of life, especially for minoritized groups or those with high distress, suggesting targeted or clinician-led care.
Read More
Promising Results From iMMagine-1 Trial : Advancement for Relapsed/Refractory MM
iMMagine-1 phase 2 trial shows 97% response, 62% complete response in relapsed/refractory myeloma, with strong safety and promising 2026 launch.
Read More
Exploring Immune Biomarkers and Tumor-Infiltrating Lymphocytes With Dr. Justin Balko
Justin Balko, PharmD, PhD, recently joined Dr. Priyanka Sharma and Dr. Roberto Salgado at the 2024 San Antonio Breast Cancer Symposium to discuss immune biomarkers, including tumor-infiltrating lymphocytes, and their roles.
Read More
Test Your Knowledge on COPD & Asthma!
A quiz based on the latest COPD and asthma news from your peers.
Read More
Test Your Knowledge of COPD Research Presented at CHEST!
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
Read More
Test Your Knowledge of Psoriasis Research Presented at Fall Clinical Dermatology Conference!
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2024? Test your knowledge now and see how you rank!
Read More
Comparing FISH vs NGS for Comprehensive Genomic Insights in Breast Cancer
NGS aligned with FISH for detecting HER2 status in patients with breast cancer, in addition to revealing ERBB2 mutations and nuanced alterations.
Read More
Alexey Danilov, MD, PhD, on Personalized Care & Prognostic Insights in CLL
Physician’s Weekly spoke with Alexey Danilov, MD, PhD, at ASH 2024 on personalized care and prognostic insights in CLL.
Read More
Telemedicine Intervention Improves Pain Intensity, Related Disability
Recent studies, including one from the ASHP Midyear Clinical Meeting, highlight strategies for achieving equitable outcomes in patients with chronic pain.
Read More
Which Factors Influence Biopsy Approach & Therapy Sequence in Metastatic ER+ Breast Cancer?
Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment sequencing in metastatic breast cancer.
Read More
Toward Consensus on Tumor-Infiltrating Lymphocytes as Prognostic Biomarkers in Triple-Negative Breast Cancer
High tumor-infiltrating lymphocyte levels (>40%) predicted improved survival in triple-negative breast cancer, emphasizing TILs as a key prognostic biomarker.
Read More
Test Your Knowledge of COPD Research!
Do you remember the recent COPD research? Test your knowledge now and see how you rank!
Read More
Test Your Knowledge of Tardive Dyskinesia!
A quiz based on the latest news and studies on tardive dyskinesia.
Read More